Aortic progression and reintervention in patients with pathogenic variants after a thoracic aortic dissection

Published:February 19, 2020DOI:



      To evaluate aortic disease progression and reintervention after an initial thoracic aortic dissection in pathogenic variant carriers.


      Of 175 participants diagnosed with thoracic aortic dissection, 31 had a pathogenic variant (pathogenic group) across 6 genes (COL3A1, FBN1, LOX, PRKG1, SMAD3, TGFBR2) identified by whole exome sequencing. Those with benign or normal variants (benign/normal group, n = 144) comprised the control group. Clinical data were collected through medical record review (1985-2018) and supplemented with the National Death Index database (December 2018).


      The entire cohort (n = 175) consisted of 108 type A aortic dissections and 67 type B aortic dissections, similarly distributed between groups. The pathogenic group was significantly younger (43 vs 56 years, P < .0001) and had significantly more aortic root replacements and similar extents of arch replacement at initial type A aortic dissection repair. The median follow-up time was 7.5 (4.6-12) years. After initial treatment, the pathogenic group required significantly more aortic reinterventions (median 1 vs 0, P < .0001) and mean cumulative aortic reinterventions for each patient (10 years: 1 vs 0.5, P = .029). Both incidence rate (12%/year vs 1.2%/year, P = .0001) and cumulative incidence of reinterventions (9 years: 70% vs 6%, P < .0001) for the preserved native aortic root were significantly higher in the pathogenic group, but were similar for the preserved native aortic arch and distal aorta between groups. Ten-year survival was similar in the pathogenic and benign/normal groups (92% vs 85%).


      Aggressive aortic root replacement and similar arch management should be considered in pathogenic variant carriers at initial type A aortic dissection repair compared with benign/normal variant carriers.

      Graphical abstract

      Key Words

      Abbreviations and Acronyms:

      CI (confidence interval), CT (computed tomography), HR (hazard ratio), LDS (Loeys–Dietz syndrome), MFS (Marfan syndrome), TAAD (type A aortic dissection), TBAD (type B aortic dissection), TEVAR (thoracic endovascular aortic repair)
      To read this article in full you will need to make a payment


      Subscribe to The Journal of Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Milewicz D.M.
        • Regalado E.
        • Adam M.P.
        • Ardinger H.H.
        • Pagon R.A.
        • Wallace S.E.
        • et al.
        Heritable thoracic aortic disease overview.
        University of Washington, Seattle, GeneReviews. Seattle, WA1993
        • Pomianowski P.
        • Elefteriades J.A.
        The genetics and genomics of thoracic aortic disease.
        Ann Cardiothorac Surg. 2013; 2: 271-279
        • Renard M.
        • Francis C.
        • Ghosh R.
        • Scott A.F.
        • Witmer P.D.
        • Ades L.C.
        • et al.
        Clinical validity of genes for heritable thoracic aortic aneurysm and dissection.
        J Am Coll Cardiol. 2018; 72: 605-615
        • Brownstein A.J.
        • Kostiuk V.
        • Ziganshin B.A.
        • Zafar M.A.
        • Kuivaniemi H.
        • Body S.C.
        • et al.
        Genes associated with thoracic aortic aneurysm and dissection: 2018 update and clinical implications.
        Aorta (Stamford). 2018; 6: 13-20
        • Wolford B.N.
        • Hornsby W.E.
        • Guo D.
        • Zhou W.
        • Lin M.
        • Farhat L.
        • et al.
        Clinical implications of identifying pathogenic variants in individuals with thoracic aortic dissection.
        Circ Genom Precis Med. 2019; 12: e002476
        • Centers for Disease Control and Prevention
        • National Center for Health Statistics
        National Death Index.
        (Available at:)
        Date accessed: December 27, 2017
        • Rylski B.
        • Bavaria J.E.
        • Beyersdorf F.
        • Branchetti E.
        • Desai N.D.
        • Milewski R.K.
        • et al.
        Type A aortic dissection in Marfan syndrome: extent of initial surgery determines long-term outcome.
        Circulation. 2014; 129: 1381-1386
        • Kari F.A.
        • Russe M.F.
        • Peter P.
        • Blanke P.
        • Rylski B.
        • Euringer W.
        • et al.
        Late complications and distal growth rates of Marfan aortas after proximal aortic repair.
        Eur J Cardiothorac Surg. 2013; 44: 163-171
        • Kimura N.
        • Aizawa K.
        • Kawahito K.
        • Itagaki R.
        • Yamaguchi A.
        • Misawa Y.
        • et al.
        Outcomes of early-onset acute type A aortic dissection- influence of etiologic factors.
        Circ J. 2019; 83: 285-294
        • Yang B.
        • Norton E.L.
        • Hobbs R.
        • Farhat L.
        • Wu X.
        • Hornsby W.E.
        • et al.
        Short- and long-term outcomes of aortic root repair and replacement in patients undergoing acute type A aortic dissection repair: 20-year experience.
        J Thorac Cardiovasc Surg. 2019; 157: 2125-2136
        • Yang B.
        • Norton E.L.
        • Shih T.
        • Farhat L.
        • Wu X.
        • Hornsby W.E.
        • et al.
        Late outcomes of strategic arch resection in acute type A aortic dissection.
        J Thorac Cardiovasc Surg. 2019; 157: 1313-1321.e2
        • Bachet J.
        Commentary: the importance of being earnest and … eclectic.
        J Thorac Cardiovasc Surg. 2019; 157: 1322-1323
        • Gillis E.
        • Van Laer L.
        • Loeys B.L.
        Genetics of thoracic aortic aneurysm: at the crossroad of transforming growth factor-beta signaling and vascular smooth muscle cell contractility.
        Circ Res. 2013; 113: 327-340
        • MacFarlane E.G.
        • Parker S.J.
        • Shin J.Y.
        • Kang B.E.
        • Ziegler S.G.
        • Creamer T.J.
        • et al.
        Lineage-specific events underlie aortic root aneurysm pathogenesis in Loeys-Dietz syndrome.
        J Clin Invest. 2019; 129: 659-675
        • Norton E.L.
        • Gordon D.
        • Yang B.
        Managing the aorta in patients with a PRKG1 mutation.
        J Thorac Cardiovasc Surg. 2019; 157: e107-e109
        • Asher S.B.
        • Chen R.
        • Kallish S.
        Mitral valve prolapse and aortic root dilation in adults with hypermobile Ehlers-Danlos syndrome and related disorders.
        Am J Med Genet A. 2018; 176: 1838-1844
        • Guo D.C.
        • Regalado E.S.
        • Gong L.
        • Duan X.
        • Santos-Cortez R.L.
        • Arnaud P.
        • et al.
        LOX mutations predispose to thoracic aortic aneurysms and dissections.
        Circ Res. 2016; 118: 928-934
        • Gong J.
        • Qiu P.
        • Chen E.
        • Yang B.
        Abstract 698: functional analysis of Smad3 deficiency in VSMCs derived from Crispr/cas9-modified human induced pluripotent stem cells.
        Arterioscler Thromb Vasc Biol. 2018; 38: 698